Literature DB >> 26049401

Fructose and uric acid in diabetic nephropathy.

Petter Bjornstad1, Miguel A Lanaspa, Takuji Ishimoto, Tomoki Kosugi, Shinji Kume, Diana Jalal, David M Maahs, Janet K Snell-Bergeon, Richard J Johnson, Takahiko Nakagawa.   

Abstract

Clinical studies have reported associations between serum uric acid levels and the development of diabetic nephropathy, but the underlying mechanisms remain elusive. There is evidence from animal studies that blocking uric acid production protects the kidney from tubulointerstitial injury, which may suggest a causal role for uric acid in the development of diabetic tubular injury. In turn, when fructose, which is endogenously produced in diabetes via the polyol pathway, is metabolised, uric acid is generated from a side-chain reaction driven by ATP depletion and purine nucleotide turnover. For this reason, uric acid derived from endogenous fructose could cause tubulointerstitial injury in diabetes. Accordingly, our research group recently demonstrated that blocking fructose metabolism in a diabetic mouse model mitigated the development of tubulointerstitial injury by lowering tubular uric acid production. In this review we discuss the relationship between uric acid and fructose as a novel mechanism for the development of diabetic tubular injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26049401      PMCID: PMC4826347          DOI: 10.1007/s00125-015-3650-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  87 in total

1.  Variation in sorbitol accumulation and polyol-pathway activity in cultured human proximal tubule cells.

Authors:  M C Flath; J E Bylander; D A Sens
Journal:  Diabetes       Date:  1992-09       Impact factor: 9.461

2.  Effect of oral fructose on urate production.

Authors:  B T Emmerson
Journal:  Ann Rheum Dis       Date:  1974-05       Impact factor: 19.103

3.  Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.

Authors:  Ali Momeni; Shahrzad Shahidi; Shiva Seirafian; Shahram Taheri; Soleiman Kheiri
Journal:  Iran J Kidney Dis       Date:  2010-04       Impact factor: 0.892

4.  Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells.

Authors:  Daniela Verzola; Maria Bianca Bertolotto; Barbara Villaggio; Luciano Ottonello; Franco Dallegri; Francesca Salvatore; Valeria Berruti; Maria Teresa Gandolfo; Giacomo Garibotto; Giacomo Deferrari
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

5.  Serum uric acid, serum glucose and diabetes: relationships in a population study.

Authors:  D G Cook; A G Shaper; D S Thelle; T P Whitehead
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

6.  Immunohistochemical localization of aldose reductase. II. Rat eye and kidney.

Authors:  M A Ludvigson; R L Sorenson
Journal:  Diabetes       Date:  1980-06       Impact factor: 9.461

7.  Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.

Authors:  Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel
Journal:  Nutr Metab (Lond)       Date:  2012-07-24       Impact factor: 4.169

8.  Association of serum uric acid with proteinuria in type 2 diabetic patients.

Authors:  Saeed Behradmanesh; Mohammad Karami Horestani; Azar Baradaran; Hamid Nasri
Journal:  J Res Med Sci       Date:  2013-01       Impact factor: 1.852

9.  SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.

Authors:  Yukihiro Chino; Yoshishige Samukawa; Soichi Sakai; Yasuhiro Nakai; Jun-ichi Yamaguchi; Takeo Nakanishi; Ikumi Tamai
Journal:  Biopharm Drug Dispos       Date:  2014-08-06       Impact factor: 1.627

10.  Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

Authors:  Andrzej S Krolewski; Monika A Niewczas; Jan Skupien; Tomhito Gohda; Adam Smiles; Jon H Eckfeldt; Alessandro Doria; James H Warram
Journal:  Diabetes Care       Date:  2013-08-12       Impact factor: 19.112

View more
  40 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

Review 2.  Acute kidney injury from SGLT2 inhibitors: potential mechanisms.

Authors:  Kai Hahn; A Ahsan Ejaz; Mehmet Kanbay; Miguel A Lanaspa; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2016-11-16       Impact factor: 28.314

Review 3.  Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?

Authors:  Ambreen Gul; Philip Zager
Journal:  Curr Diab Rep       Date:  2018-03-01       Impact factor: 4.810

4.  Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes.

Authors:  Petter Bjornstad; David M Maahs; Carlos A Roncal; Janet K Snell-Bergeon; Viral N Shah; Tamara Milagres; Samuel L Ellis; Matthew Hatch; Linh T Chung; Marian J Rewers; Satish Garg; David Z Cherney; Laura Pyle; Kristen J Nadeau; Richard J Johnson
Journal:  Diabetes Obes Metab       Date:  2018-03-24       Impact factor: 6.577

5.  Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.

Authors:  Ying Shao; Huiwen Ren; Chuan Lv; Xiaoyu Ma; Can Wu; Qiuyue Wang
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

6.  Fructose tolerance test in obese people with and without type 2 diabetes.

Authors:  Ebaa Al-Ozairi; Christopher J Rivard; Laura Gabriela Sanchez Lozada; Miguel A Lanaspa; Petter Bjornstad; Danah Al Salem; Asma Alhubail; Amira Megahed; Masanari Kuwabara; Richard J Johnson; Reem A Asad
Journal:  J Diabetes       Date:  2019-09-18       Impact factor: 4.006

Review 7.  Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

8.  Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.

Authors:  Petter Bjornstad; Laura Pyle; David Z I Cherney; Richard J Johnson; Rachel Sippl; Randy Wong; Marian Rewers; Janet K Snell-Bergeon
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

9.  Hyperfiltration and uricosuria in adolescents with type 1 diabetes.

Authors:  Petter Bjornstad; Carlos Roncal; Tamara Milagres; Laura Pyle; Miguel Angel Lanaspa; Franziska K Bishop; Janet K Snell-Bergeon; Richard J Johnson; R Paul Wadwa; David M Maahs
Journal:  Pediatr Nephrol       Date:  2015-12-23       Impact factor: 3.714

10.  Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Petter Bjornstad; Mark H H Kramer; Michaela Diamant; Ewout J Hoorn; Jaap A Joles; Daniël H van Raalte
Journal:  Diabetes Obes Metab       Date:  2018-02-20       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.